The Scottish Medicines Consortium (SMC) has agreed that PrEP, a drug which dramatically reduces the chances of being infected with HIV, is to be made available on the NHS in Scotland.
Scientists found that a daily dose of the drug can protect people at risk of contracting the virus. Pre-exposure prophylaxis (Prep) taken once a day has been found to reduce the risk of HIV infection by 86%. It is currently used in the US, Canada, Australia and France to help protect gay men at the highest risk of contracting HIV.
In December NHS England announced plans for a large scale clinical trial of the drug, expected to involve 10,000 participants over three years. HIV often remains a stigmatised condition and we hope that NHS England will seriously consider following Scotland’s lead in providing this preventative measure to protect at risks groups such as gay men.